http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016503775-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
| filingDate | 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016503775-A |
| titleOfInvention | Novel tricyclic 3,4-dihydro-2H-pyrido [1,2-a] pyrazine-1,6-dione derivatives as gamma secretase modulators |
| abstract | The present invention relates to a compound of formula (I) [Chemical 1] A novel tricyclic 3,4-dihydro-2H-pyrido [1,2-a] pyrazine-1,6-dione derivative wherein R 1 , R 2 , R 3 , R 4 , L, Y, Z and X have the meanings defined in the claims]. The compounds according to the invention are useful as γ-secretase modulators. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said compounds as active ingredients, and in particular the use of said compounds as pharmaceuticals for treating Alzheimer's disease. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018528174-A |
| priorityDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 205.